Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation

Hong Seok Choi1, Bu Young Choi, Yong-Yeon Cho

  • 1Hormel Institute, University of Minnesota, Austin, Minnesota 55912, USA.

Cancer Research
|July 5, 2005
PubMed

Insights

Histone H3 phosphorylation, specifically at Ser10, is crucial for epidermal growth factor (EGF)-induced cell transformation and cancer development. Modulating histone H3 levels impacts neoplastic cell growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The role of histone H3 phosphorylation in cancer development is largely unknown.
  • Histone modifications are critical regulators of gene expression and cellular processes.

Purpose of the Study:

  • To investigate the function of histone H3 phosphorylation in malignant cell transformation.
  • To elucidate the specific role of histone H3 phosphorylation at Ser10 in epidermal growth factor (EGF)-induced transformation.

Main Methods:

  • Utilized small interfering RNA (siRNA) to reduce histone H3 levels in JB6 cells.
  • Overexpressed wild-type histone H3 (H3 WT) and histone H3 mutants (S10A, S28A) in JB6 cells.
  • Assessed EGF-induced cell transformation, c-fos and c-jun promoter activity, and activator protein-1 (AP-1) activity.

Main Results:

  • Reduced histone H3 levels decreased EGF-induced cell transformation.
  • Overexpression of H3 WT stimulated EGF-induced transformation, while the S10A mutant suppressed it.
  • H3 WT overexpression enhanced EGF induction of c-fos, c-jun, and AP-1 activity, unlike S10A and S28A mutants.

Conclusions:

  • Histone H3 phosphorylation at Ser10 is essential for EGF-induced neoplastic cell transformation.
  • Histone H3 phosphorylation regulates key genes and signaling pathways involved in cell transformation.

Related Concept Videos

Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...